Rationalizing mAb Candidate Screening Using a Single Holistic Developability Parameter.
Willis LF, Trayton I, Saunders JC, Brùque MG, Davis Birch W, Westhead DR, Day K, Bond NJ, Devine PWA, Lloyd C, Kapur N, Radford SE, Darton NJ, Brockwell DJ.
Willis LF, et al.
Mol Pharm. 2025 Jan 6;22(1):181-195. doi: 10.1021/acs.molpharmaceut.4c00829. Epub 2024 Dec 16.
Mol Pharm. 2025.
PMID: 39681988
Free PMC article.